In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.

A new review paper led by senior research scientist Chun-Long Chen and featured on the cover of Accounts of Chemical Research summarizes advances by PNNL scientists in developing sequence-defined peptoids.

Beginning in 2021, PNNL chemical physicist Bruce Kay begins a three-year term as an AVS trustee, part of a six-member committee responsible for overseeing the administration of student scholarships and major society awards.

Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.

A zoonotic coronavirus known as SADS-CoV that has killed many pigs has the ability to infect human cells, surprising scientists.

A PNNL engineering team has designed personal protective equipment in support of COVID-19 aid.

The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.

In a new review, PNNL researchers outline how to convert stranded biomass to sustainable fuel using electrochemical reduction reactions in mini-refineries powered by renewable energy.

The PNNL-led IDREAM Energy Frontier Research Center is exploring complex chemical phenomena to enable innovations in radioactive waste processing.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.

Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.

PNNL and Oklahoma State University join forces to understand the chemistry of sodium-ion and potassium-ion batteries thanks to an award from the U.S. Department of Energy's Established Program to Stimulate Competitive Research (EPSCoR).

The PNNL chemist is leading a joint effort to study circadian rhythms and the gut microbiome.

Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.

Joint appointments at UW and OSU help PNNL’s Katrina Waters further collaborations in infectious disease and toxicology research.

PNNL computational biologist Bobbie-Jo Webb-Robertson was recently awarded the “Spirit of nPOD award” to acknowledge her hard work in building, coordinating, and leading the Data Science Working Group.

To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.

PNNL biomedical scientist Ernesto Nakayasu brings expertise in host-pathogen interactions and the interconnection between the immune response and cellular metabolism to provide constructive review for submitted manuscripts.

After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.